EUROASPIRE III: A comparison between Turkey and Europe;EUROASPIRE III: Türkiye ile Avrupa'nin karşilaştirilmasi

Turk Kardiyoloji Dernegi Arsivi

Volumn 38, Issue 3, 2010, Pages 164-172

  Tokgözoǧlu, Lale ^a   Kaya, Ergün Bariş ^a   Erol, Çetin ^b   Ergene, Oktay ^c   Aydoǧdu, Sinan ^d   Tekin, Meltem ^d   Tulunay, Cansin ^b   Çengel, Atiye ^e   Kocaman, Sinan Altan ^e   Işik, Ersoy ^f   Yokuşoǧlu, Mehmet ^f   Kabakci, Giray ^a   Temizhan, Ahmet ^f   Öziü, Fatih ^f   Çam, Neşe ^f   Uyarel, Hüseyin ^f   Aytekin, Vedat ^f   Erdim, Refik ^f   Oǧuz, Aytekin ^f   Uzunlulu, Mehmet ^f   Okay, Tuǧrul ^g   Erdoǧan, Işik ^g   Öngen, Zeki ^h   FirincioǧulIari, Habbaş ^h   Koylan, Nevres ⁱ   Altun, Ibrahim ⁱ   Kayabilge, Ahmet ⁱ   Sansoy, Vedat ^j   Uzunhasan, Işil ^j   Yaymaci, Bengi ^f   Turan, Burak ^f   Yüksek, Ümit ^c   Orul, Türkay ^c   Güneri, Sema ^k   Özen, Erdem ^k   Kültürsay, Hakan ^l   Kayikçioǧlu, Meral ^l   more..

^a HACETTEPE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e GAZI UNIVERSITY   (Turkey)

^f International Hospital ^*  (Turkey)

^g International Hospital   (Turkey)

^h ISTANBUL UNIVERSITY   (Turkey)

ⁱ ISTANBUL UNIVERSITY   (Turkey)

^j ISTANBUL UNIVERSITY   (Turkey)

^k DOKUZ EYLUL UNIVERSITY   (Turkey)

^l EGE UNIVERSITY   (Turkey)

more..

Author keywords

Cardiovascular diseases prevention control; Coronary disease prevention control; Life style; Risk factors; Turkey epidemiology

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY RISK; EUROPE; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; IMMOBILIZATION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; INTERVIEW; ISCHEMIC HEART DISEASE; LIFESTYLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT EDUCATION; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; TURKEY (REPUBLIC); WAIST CIRCUMFERENCE;

CORONARY DISEASE; EUROPE; FEMALE; HEALTH SURVEYS; HUMANS; LIFE STYLE; MALE; MYOCARDIAL INFARCTION; PATIENT EDUCATION AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TURKEY;

EID: 77955443356     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts); Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007;28:2375-414.
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-57.
3. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
4. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
5. Resch M, Wiest R, Moleda L, Fredersdorf S, Stoelcker B, Schroeder JA, et al. Alterations in mechanical properties of mesenteric resistance arteries in experimental portal hypertension. Am J Physiol Gastrointest Liver Physiol 2009 Aug 20. doi:10.1152/ajpgi.00084.20090193-1857/09 [Epub ahead of print]
6. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001;156:1-10.
7. Onat A, Keleş İ, Çetinkaya A, Başar Ö, Yildirim B, Erer B, et al. Prevalence of all-cause and coronary mortality in Turkish adults as assessed by 10-year follow-up data of the Turkish adult risk factor study. [Article in Turkish] Türk Kardiyol Dem Arş 2001; 29:8-19.
8. Mahley RW, Palaoǧlu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, et al. Turkish Heart Study: lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995;36:839-59.
9. Satman I, Yilmaz T, Şengül A, Salman S, Salman F, Uygur S, et al. Population-based study of diabetes and risk characteristics in Turkey: results of the Turkish Diabetes Epidemiology Study (TURDEP). Diabetes Care 2002;25:1551-6.
10. Altun B, Arici M, Nergizoǧlu G, Derici U, Karatan O, Turgan C, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens 2005;23:1817-23.
11. Abaci A, Oǧuz A, Kozan O, Toprak N, Şenocak H, Deǧer N, et al. Treatment and control of hypertension in Turkish population: a survey on high blood pressure in primary care (the TURKSAHA study). J Hum Hypertens 2006;20:355-61.
12. Tokgözoǧlu L, Bariş Kaya E. Atherosclerotic vascular disease and risk factors in Turkey: from past to present. J Atheroscler Thromb 2008;15:286-91.
13. EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events. Eur Heart J 1997;18:1569-82.
14. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554-72.
15. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009;16:121-37.
16. Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000;160:939-44.
17. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298-304.
18. Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004;116:682-92.
19. Hodoǧlugil U, Mahley RW. Smoking and obesity make a bad problem worse: genetics and lifestyle affect high density lipoprotein levels in Turks. Anadolu Kardiyol Derg 2006;6:60-7.